• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Volato Announces Changes to Board Composition

    4/24/24 6:00:00 AM ET
    $BSX
    $SOAR
    $NVCN
    Medical/Dental Instruments
    Health Care
    Transportation Services
    Consumer Discretionary
    Get the next $BSX alert in real time by email

    Volato to Announce First Quarter 2024 Results on Wednesday, May 15, 2024

    Volato Group, Inc. ("Volato," or the "Company") (NYSE:SOAR) today announced that it has appointed Christopher G. Burger and Fred A. Colen to the Company's Board of Directors. As part of this announcement, Joan Sullivan Garrett, Katherine Arris-Wilson, Peter Mirabello, and Dana H. Born have stepped down from the Company's Board of Directors without disagreement.

    The company is decreasing the size of its board from seven to five members, three of whom are Independent Directors. Fred Colen will serve as an independent director and Chair of the Audit Committee and has been designated as a financial expert. Chris Burger will serve as an independent director and Chair of the Nominating and Corporate Governance Committee. Michael Nichols has served as an independent director since August of 2021 and has been elected as Lead Independent Director; Mr. Nichols will continue to serve as Chair of the Compensation Committee. Matthew Liotta, Chief Executive Officer and Co-Founder of Volato, has been elected Chairman of the Board of Directors. Nicholas Cooper, Chief Commercial Officer and co-founder, will continue to serve as a director.

    Mr. Liotta commented, "I'd like to thank each of the departing directors for their service to Volato. We are very pleased to introduce Chris Burger and Fred Colen to our upgraded board structure, bringing with them an exceptional mix of expertise in technology and aviation. This strategic enhancement of our board will sharpen our decision-making and accelerate our financial goals. With their guidance and a more nimble board structure, we are poised to drive Volato forward, reinforcing our commitment to innovation in the private aviation industry."

    Christopher G. Burger Bio

    Chris Burger is a proven senior executive, C-level advisor, and Board member with extensive experience leading global organizations through critical business and technology transformation initiatives. Chris has direct international management experience spanning five continents and currently serves as President & CEO of Transform with a mission to help clients and team members achieve their greatest potential and fulfillment. Notable Transform Aviation clients include, among others, Delta Air Lines, FedEx, United Airlines, and USAF Air Mobility Command. Earlier in his career, Chris held roles of increasing responsibility at GE and Motorola across digitization, acquisition integration, program and project management, strategic programs, global business planning and competitive intelligence. Chris holds a Bachelor of Business Administration degree with a Marketing Distinction Certificate from Emory University's Roberto C. Goizueta Business School.

    Fred A. Colen Bio

    Mr. Colen is an experienced public company executive and director. He has served as Chairman of the Board of Xeltis AG, an international medical device company, since 2023. Since 2017, Mr. Colen has served on the Board of Directors of Onward Medical (Euronext: ONWD). From January 2018 to April 2023, he served as the President and Chief Executive Officer of Neovasc Inc. (NASDAQ:NVCN). Prior to joining Neovasc Inc., Mr. Colen served as the President and Chief Executive Officer at BeneChill, Inc., a medical device company in San Diego, California, from 2011 to 2016. Before joining BeneChill, Inc., Mr. Colen served in various capacities at Boston Scientific (NYSE:BSX) from 1999 to 2010. Mr. Colen holds a Master of Electrical Engineering with a specialization in Biomedical Engineering from the University of Aachen in Germany. Mr. Colen is qualified to serve on the Board because of his significant public company board and managerial experience.

    The departing board members' resignations are not related to any disagreement with the Company on any matter relating to the Company's operations, policies, or practices.

    Earnings Conference Call

    Volato will release its financial results for the first quarter ended March 31, 2024, before market open on Wednesday, May 15, 2024. and will host a conference call to discuss the results at 8:00am ET on the same day.

    Interested parties can access the conference call by dialing 866-605-1830 for toll free access or +1 215-268-9881. The live call will also be available via webcast on Volato's Investor Relations website: https://ir.flyvolato.com/.

    A replay of the call will be available until August 14, 2024 and can be accessed by dialing 877-660-6853 or 201-612-7415 and using the Access ID: 13746297.

    Cautionary Note on Forward Looking Statements

    This press release contains certain "forward-looking statements" within the meaning of the federal securities laws. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside of the control of Volato that could cause actual results to differ materially from the results discussed in the forward-looking statements. The words "anticipate," "believe," continue," "could," "estimate," "expect," "intend," "may," "might," "plan," "possible," "potential," "predict," "project," "should," "strive," "would" and similar expressions may identify forward-looking statements, but the absence of these words does not mean that statement is not forward-looking. These forward-looking statements are subject to a number of risks, uncertainties and assumptions that could cause actual events and results to differ materially from those contained in such forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied in forward-looking statements can be found in the Annual Report on Form 10-K, filed with the SEC on March 26, 2024 and other documents filed by the Company from time to time with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. You are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made, and Volato undertakes no obligation and does not intend to update or revise these forward-looking statements, whether because of new information, future events, or otherwise.

    About Volato

    Volato (NYSE:SOAR) is a leader in private aviation, redefining air travel through modern, efficient, and customer-designed solutions. Volato provides a fresh approach to fractional ownership, aircraft management, jet card, deposit and charter programs, all powered by advanced, proprietary mission control technology. Volato's fractional programs uniquely offer flexible hours and a revenue share for owners across the world's largest fleet of HondaJets, which are optimized for missions of up to four passengers. For more information visit www.flyvolato.com.

    All Volato Part 135 charter flights are operated by its DOT/FAA-authorized air carrier subsidiary (G C Aviation, Inc. d/b/a Volato) or by an approved vendor air carrier.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20240423912104/en/

    Get the next $BSX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BSX
    $SOAR
    $NVCN

    CompanyDatePrice TargetRatingAnalyst
    Boston Scientific Corporation
    $BSX
    10/3/2025Buy → Hold
    Erste Group
    Boston Scientific Corporation
    $BSX
    9/8/2025$125.00Perform → Outperform
    Oppenheimer
    Boston Scientific Corporation
    $BSX
    6/16/2025$118.00Outperform
    Leerink Partners
    Boston Scientific Corporation
    $BSX
    4/16/2025$113.00Hold → Buy
    Needham
    Boston Scientific Corporation
    $BSX
    1/10/2025$108.00Hold → Buy
    Deutsche Bank
    Boston Scientific Corporation
    $BSX
    10/18/2024Buy → Hold
    Needham
    Boston Scientific Corporation
    $BSX
    5/30/2024$90.00Buy
    Goldman
    Boston Scientific Corporation
    $BSX
    2/1/2024$65.00 → $80.00Neutral → Buy
    Mizuho
    More analyst ratings

    $BSX
    $SOAR
    $NVCN
    SEC Filings

    View All

    Amendment: Volato Group Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K/A - Volato Group, Inc. (0001853070) (Filer)

    12/12/25 5:15:48 PM ET
    $SOAR
    Transportation Services
    Consumer Discretionary

    Volato Group Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - Volato Group, Inc. (0001853070) (Filer)

    12/8/25 5:15:53 PM ET
    $SOAR
    Transportation Services
    Consumer Discretionary

    SEC Form 424B5 filed by Volato Group Inc.

    424B5 - Volato Group, Inc. (0001853070) (Filer)

    12/8/25 5:00:40 PM ET
    $SOAR
    Transportation Services
    Consumer Discretionary

    $BSX
    $SOAR
    $NVCN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    CathVision Announces Appointment of Eric Thepaut as Independent Chairman of the Board and Releases ECGenius® System Version 3.5

    COPENHAGEN, Denmark, Dec. 10, 2025 /PRNewswire/ -- CathVision, a medical technology company dedicated to improving clinical outcomes in cardiac electrophysiology through high-fidelity signal acquisition and intelligent software, today announced two major milestones: the appointment of Eric Thepaut as independent Chairman of the Board, and the commercial release of Version 3.5 of the ECGenius® System. Eric Thepaut Appointed Independent Chairman of the Board Eric Thepaut joins CathVision following his recent retirement from Boston Scientific Corporation (NYSE:BSX), where he serv

    12/10/25 4:00:00 AM ET
    $BSX
    Medical/Dental Instruments
    Health Care

    M2i Global and Volato Group Announce MOU with Nimy Resources for Access to Gallium from Western Australia

    Greatly Enhances its Critical Minerals Supply Chain Atlanta, GA and Reno, NV, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Volato Group, Inc. ("Volato") (NYSE:SOAR), a technology-driven company and M2i Global, Inc. ("M2i Global") (OTCQB:MTWO), a company specializing in the development and execution of a complete global value supply chain for critical minerals, today announced that Nimy Resources ("Nimy") and M2i will collaborate with the aim of forming commercially binding contract terms for the respective sale and purchase of gallium production. Currently, the United States has no domestic production of primary gallium metal and relies on imports for 100% of its supply. A significant portion of th

    11/19/25 8:30:00 AM ET
    $SOAR
    Transportation Services
    Consumer Discretionary

    Volato Takes Delivery of Fourth Gulfstream G280 in Q4 2025, Expects Strong Market Demand for the Premium Jet

    Volato Group, Inc. (the "Company" or "Volato") (NYSE:SOAR), today announced the delivery of its fourth Gulfstream G280 in the fourth quarter 2025. This milestone reflects Volato's strategy to capitalize on strong market demand for premium super-midsize jets. The Gulfstream G280 remains one of the most desirable aircraft in its class, with a range of up to 3,600 nautical miles, advanced performance, and a spacious, luxurious cabin. As the private aviation market faces constrained supply and significant backlogs, Volato's ability to secure timely deliveries creates a unique opportunity to meet rising customer demand through aircraft sales. "This delivery marks the fourth Gulfstream G280 f

    11/18/25 8:00:00 AM ET
    $SOAR
    Transportation Services
    Consumer Discretionary

    $BSX
    $SOAR
    $NVCN
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    March 1, 2024 - FDA Roundup: March 1, 2024

    For Immediate Release: March 01, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA issued a letter of enforcement discretion for certain qualified health claims regarding the consumption of yogurt and the reduced risk of type 2 diabetes. The letter states that the FDA does not intend to object to the use of these claims, provide

    3/1/24 4:00:21 PM ET
    $BSX
    Medical/Dental Instruments
    Health Care

    $BSX
    $SOAR
    $NVCN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Boston Scientific downgraded by Erste Group

    Erste Group downgraded Boston Scientific from Buy to Hold

    10/3/25 8:32:04 AM ET
    $BSX
    Medical/Dental Instruments
    Health Care

    Boston Scientific upgraded by Oppenheimer with a new price target

    Oppenheimer upgraded Boston Scientific from Perform to Outperform and set a new price target of $125.00

    9/8/25 8:36:41 AM ET
    $BSX
    Medical/Dental Instruments
    Health Care

    Leerink Partners initiated coverage on Boston Scientific with a new price target

    Leerink Partners initiated coverage of Boston Scientific with a rating of Outperform and set a new price target of $118.00

    6/16/25 7:46:14 AM ET
    $BSX
    Medical/Dental Instruments
    Health Care

    $BSX
    $SOAR
    $NVCN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider O'Connor Padraig Andrew claimed ownership of 3,885 shares (SEC Form 3)

    3 - BOSTON SCIENTIFIC CORP (0000885725) (Issuer)

    12/8/25 4:49:37 PM ET
    $BSX
    Medical/Dental Instruments
    Health Care

    EVP& Grp Pres, MedSurg & APAC Butcher Arthur C sold $1,758,189 worth of shares (17,313 units at $101.55) and exercised 17,313 shares at a strike of $24.81 (SEC Form 4)

    4 - BOSTON SCIENTIFIC CORP (0000885725) (Issuer)

    12/2/25 5:04:07 PM ET
    $BSX
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Boston Scientific Corporation

    4 - BOSTON SCIENTIFIC CORP (0000885725) (Issuer)

    12/1/25 5:06:57 PM ET
    $BSX
    Medical/Dental Instruments
    Health Care

    $BSX
    $SOAR
    $NVCN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP & Group Pres, Cardiology Fitzgerald Joseph Michael bought $4,515 worth of shares (50 units at $90.29), sold $1,799 worth of shares (20 units at $89.97), was granted 31,680 shares and covered exercise/tax liability with 14,447 shares, increasing direct ownership by 17% to 172,863 units (SEC Form 4)

    4 - BOSTON SCIENTIFIC CORP (0000885725) (Issuer)

    2/13/25 4:32:41 PM ET
    $BSX
    Medical/Dental Instruments
    Health Care

    Chief Operating Officer Prachar Michael Patrick bought $988 worth of shares (1,235 units at $0.80) (SEC Form 4)

    4 - Volato Group, Inc. (0001853070) (Issuer)

    6/10/24 6:38:24 PM ET
    $SOAR
    Transportation Services
    Consumer Discretionary

    Chief Executive Officer Liotta Matthew bought $4,860 worth of shares (6,000 units at $0.81), increasing direct ownership by 0.13% to 4,797,271 units (SEC Form 4)

    4 - Volato Group, Inc. (0001853070) (Issuer)

    6/10/24 6:35:35 PM ET
    $SOAR
    Transportation Services
    Consumer Discretionary

    $BSX
    $SOAR
    $NVCN
    Leadership Updates

    Live Leadership Updates

    View All

    CathVision Announces Appointment of Eric Thepaut as Independent Chairman of the Board and Releases ECGenius® System Version 3.5

    COPENHAGEN, Denmark, Dec. 10, 2025 /PRNewswire/ -- CathVision, a medical technology company dedicated to improving clinical outcomes in cardiac electrophysiology through high-fidelity signal acquisition and intelligent software, today announced two major milestones: the appointment of Eric Thepaut as independent Chairman of the Board, and the commercial release of Version 3.5 of the ECGenius® System. Eric Thepaut Appointed Independent Chairman of the Board Eric Thepaut joins CathVision following his recent retirement from Boston Scientific Corporation (NYSE:BSX), where he serv

    12/10/25 4:00:00 AM ET
    $BSX
    Medical/Dental Instruments
    Health Care

    Volato Group's Proposed Acquisition Under Definitive Agreement, M2i Global Names Anthony Roger Moore to its Board of Advisors

    Atlanta, GA and Reno, NV, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Volato Group, Inc. ("Volato") (NYSE:SOAR), a technology-driven private aviation company and M2i Global, Inc. ("M2i Global") (OTCQB:MTWO), a company specializing in the development and execution of a complete global value supply chain for critical minerals, is pleased to announce that Anthony Roger Moore, a global financial services professional with more than 55 years' experience with business transactions spanning over 30 countries, has joined the Company's Advisory Board. M2i's ecosystem provides partners with access to turnkey solutions, facilitating expanded business opportunities, securing offtake agreements, influencing str

    10/1/25 8:30:00 AM ET
    $SOAR
    Transportation Services
    Consumer Discretionary

    Volato Group's Proposed Acquisition Under Definitive Agreement, M2i Global Appoints Jon Najarian as a Senior Advisor

    Atlanta, GA and Reno, NV, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Volato Group, Inc. ("Volato") (NYSE:SOAR), a technology-driven private aviation company and M2i Global, Inc. ("M2i Global") (OTCQB:MTWO), a company specializing in the development and execution of a complete global value supply chain for critical minerals, is pleased to announce that Jon Najarian, a renowned market analyst and media personality, has joined M2i Global's Advisory Board. M2i's ecosystem provides partners with access to turnkey solutions, facilitating expanded business opportunities, securing offtake agreements, influencing strategic government policy, engaging with aligned NGOs, and trusted laboratories.  Major Gen

    8/12/25 9:00:00 AM ET
    $SOAR
    Transportation Services
    Consumer Discretionary

    $BSX
    $SOAR
    $NVCN
    Financials

    Live finance-specific insights

    View All

    Boston Scientific announces results for third quarter 2025

    MARLBOROUGH, Mass., Oct. 22, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $5.065 billion during the third quarter of 2025, growing 20.3 percent on a reported basis, 19.4 percent on an operational1 basis and 15.3 percent on an organic2 basis, all compared to the prior year period. The company reported GAAP net income attributable to Boston Scientific common stockholders of $755 million or $0.51 per share (EPS), compared to $469 million or $0.32 per share a year ago, and achieved adjusted3 EPS of $0.75 for the period, compared to $0.63 a year ago.

    10/22/25 6:30:00 AM ET
    $BSX
    Medical/Dental Instruments
    Health Care

    flyExclusive Announces Strategic Acquisition of Volato's Aircraft Sales Division, Vaunt Platform, and Mission Control Software

    Structured transaction delivers immediate aviation value and secures future growth assets flyExclusive, Inc. (NYSEAMERICAN: FLYX) ("flyExclusive" or the "Company"), a leading provider of premium private jet experiences, today announced it has entered into a structured agreement with Volato Group, Inc. (NYSEAMERICAN: SOAR) to acquire Volato's aircraft sales division, expected to generate $6-8 million in profit in fourth quarter 2025, for $2.1 million in stock. The agreement also grants flyExclusive the right to acquire additional high-growth technology platforms, including Vaunt, a luxury experiential travel app providing access to private jet empty legs, and Mission Control, a cutting edg

    10/7/25 9:07:00 AM ET
    $FLYX
    $SOAR
    Transportation Services
    Consumer Discretionary

    Boston Scientific announces 2025 Investor Day meeting and conference call discussing third quarter 2025 results

    MARLBOROUGH, Mass., Sept. 2, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE:BSX) will host a meeting with the investor community to review its financial goals and long-term growth strategies on Tuesday, September 30, 2025, beginning at 8:30 a.m. ET. The Investor Day meeting will be held in hybrid format with a simultaneous online webcast. Investors and other interested parties may register for the webcast by visiting the events section on the company's investor website at https://investors.bostonscientific.com. A replay and summary materials from the presentations wi

    9/2/25 8:00:00 AM ET
    $BSX
    Medical/Dental Instruments
    Health Care

    $BSX
    $SOAR
    $NVCN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Volato Group Inc.

    SC 13G/A - Volato Group, Inc. (0001853070) (Subject)

    11/14/24 7:58:49 AM ET
    $SOAR
    Transportation Services
    Consumer Discretionary

    SEC Form SC 13G/A filed by Boston Scientific Corporation (Amendment)

    SC 13G/A - BOSTON SCIENTIFIC CORP (0000885725) (Subject)

    2/13/24 5:00:46 PM ET
    $BSX
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by Boston Scientific Corporation (Amendment)

    SC 13G/A - BOSTON SCIENTIFIC CORP (0000885725) (Subject)

    2/9/24 11:49:03 AM ET
    $BSX
    Medical/Dental Instruments
    Health Care